Pharmacologic Management of High-Risk Neuroblastoma in Children

被引：0
|
作者：
Veena R. Ganeshan
Nina F. Schor
机构：
[1] University of Rochester School of Medicine and Dentistry,Center for Neural Development and Disease, and Department of Pediatrics
[2] University of Rochester Medical Center,Department of Pediatrics
来源：
Pediatric Drugs | 2011年 / 13卷
关键词：
Neuroblastoma; Topotecan; Minimal Residual Disease; Anaplastic Lymphoma Kinase; Isotretinoin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Neuroblastoma is the most common extracranial solid tumor of childhood. It accounts for 15% of pediatric cancer deaths. Children with high-risk disease have a 3-year event-free survival rate of only 20%. Chemotherapy is the mainstay of treatment in children with advanced neuroblastoma.
引用
收藏
页码：245 / 255
页数：10
相关论文
共 50 条
  • [21] The management of high-risk lymphoblastic leukaemia in children
    Chessells, JM
    BRITISH JOURNAL OF HAEMATOLOGY, 2000, 108 (02) : 204 - 216
  • [22] Improving Outcomes in Children With High-Risk Neuroblastoma: The Role of Randomized Trials
    DuBois, Steven G.
    Bagatell, Rochelle
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (23) : 2525 - +
  • [23] Efficacy of proton therapy in children with high-risk and locally recurrent neuroblastoma
    Bagley, Alexander F.
    Grosshans, David R.
    Philip, Nancy, V
    Foster, Jennifer
    McAleer, Mary Frances
    McGovern, Susan L.
    Lassen-Ramshad, Yasmin
    Mahajan, Anita
    Paulino, Arnold C.
    PEDIATRIC BLOOD & CANCER, 2019, 66 (08)
  • [24] The Impact of Gross Total Resection on Survival in Children with High-Risk Neuroblastoma
    Komatsu, Shugo
    Saito, Takeshi
    Terui, Keita
    Nakata, Mitsuyuki
    Harada, Kazuaki
    Shinno, Yoshitaka
    Katsumi, Daisuke
    Furugane, Ryoya
    Yoshida, Hideo
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S39 - S39
  • [25] INADEQUATE RESPONSE TO INDUCTION CHEMOTHERAPY IN CHILDREN WITH HIGH-RISK NEUROBLASTOMA: AN INSTITUTIONAL
    Schrey, D.
    Vaidya, S.
    Levine, D.
    Moreno, L.
    Pearson, A.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 111 - 111
  • [26] Management of children with high-risk Hodgkin lymphoma
    Kelly, Kara M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 157 (01) : 3 - 13
  • [27] Unrelated cord blood transplantation for children with high-risk or relapsed neuroblastoma
    Takahashi, Y.
    Matsumoto, K.
    Fujisaki, H.
    Iwasaki, F.
    Hashii, Y.
    Nakamura, K.
    Sugita, K.
    Yabe, H.
    Kato, K.
    Takanashi, M.
    Atsuta, Y.
    Inoue, M.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S47 - S47
  • [28] Renal Autotransplantation for Resection of Bilateral Nephroblastoma and High-Risk Neuroblastoma in Children
    Mayer, Benjamin F. B.
    Schunn, Matthias C.
    Urla, Cristian
    Weinpert, Lea
    Tsiflikas, Ilias
    Ebinger, Martin
    Fideler, Frank
    Neunhoeffer, Felix
    Weitz, Marcus
    Nadalin, Silvio
    Warmann, Steven W.
    Fuchs, Joerg
    CANCERS, 2025, 17 (06)
  • [29] Rapid-sequence tandem transplant for children with high-risk neuroblastoma
    Grupp, SA
    Stern, JW
    Bunin, N
    Nancarrow, C
    Adams, R
    Gorlin, JB
    Griffin, G
    Diller, L
    MEDICAL AND PEDIATRIC ONCOLOGY, 2000, 35 (06): : 696 - 700
  • [30] The importance of local control management in high-risk neuroblastoma in South Africa
    van Heerden, Jaques
    Kruger, Mariana
    Esterhuizen, Tonya
    Hendricks, Marc
    Geel, Jennifer
    Buchner, Ane
    Naidu, Gita
    du Plessis, Jan
    Vanemmenes, Barry
    Uys, Ronelle
    Hadley, G. P.
    PEDIATRIC SURGERY INTERNATIONAL, 2020, 36 (04) : 457 - 469
12345